Nuveen Asset Management, LLC Geron Corp Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Geron Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 1,965,897 shares of GERN stock, worth $8.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,965,897

Previous 1,500,975 30.97%

Holding current value

$8.98 Million

Previous $4.95 Million 68.28%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$3.1 - $5.09 $1.44 Million - $2.37 Million	464,922 Added 30.97%	1,965,897 $8.34 Million
Q1 2024 May 13, 2024	BUY	$1.75 - $3.44 $18,215 - $35,806	10,409 Added 0.7%	1,500,975 $4.95 Million
Q4 2023 Feb 14, 2024	BUY	$1.74 - $2.31 $43,242 - $57,408	24,852 Added 1.7%	1,490,566 $3.15 Million
Q3 2023 Nov 14, 2023	BUY	$2.11 - $3.28 $199,899 - $310,743	94,739 Added 6.91%	1,465,714 $3.11 Million
Q2 2023 Aug 14, 2023	BUY	$1.97 - $3.69 $98,027 - $183,614	49,760 Added 3.77%	1,370,975 $4.4 Million
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $823,324 - $1.31 Million	384,731 Added 41.08%	1,321,215 $2.87 Million
Q4 2022 Feb 14, 2023	SELL	$2.03 - $2.42 $161,596 - $192,641	-79,604 Reduced 7.83%	936,484 $5.83 Million
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $536 - $943	321 Added 0.03%	1,016,088 $6.33 Million
Q2 2022 Aug 15, 2022	SELL	$1.19 - $1.65 $157,749 - $218,728	-132,563 Reduced 11.54%	1,015,767 $6.33 Million
Q1 2022 May 16, 2022	BUY	$0.99 - $1.6 $11,431 - $18,475	11,547 Added 1.02%	1,148,330 $7.15 Million
Q4 2021 Feb 14, 2022	SELL	$1.22 - $1.72 $131,325 - $185,147	-107,644 Reduced 8.65%	1,136,783 $7.08 Million
Q3 2021 Nov 12, 2021	BUY	$1.2 - $1.5 $90,300 - $112,875	75,250 Added 6.44%	1,244,427 $7.75 Million
Q2 2021 Aug 16, 2021	SELL	$1.25 - $1.83 $65,672 - $96,144	-52,538 Reduced 4.3%	1,169,177 $7.28 Million
Q1 2021 May 17, 2021	SELL	$1.52 - $2.1 $56,519 - $78,086	-37,184 Reduced 2.95%	1,221,715 $7.61 Million
Q4 2020 Feb 16, 2021	SELL	$1.55 - $2.05 $57 - $75	-37 Reduced -0.0%	1,258,899 $7.84 Million
Q3 2020 Nov 16, 2020	BUY	$1.59 - $2.19 $651,486 - $897,330	409,740 Added 48.25%	1,258,936 $7.84 Million
Q2 2020 Aug 14, 2020	BUY	$1.05 - $2.18 $165,090 - $342,759	157,229 Added 22.72%	849,196 $5.29 Million
Q1 2020 May 14, 2020	SELL	$0.89 - $1.49 $501 - $840	-564 Reduced 0.08%	691,967 $823,000
Q4 2019 Feb 14, 2020	SELL	$1.27 - $1.54 $13,030 - $15,800	-10,260 Reduced 1.46%	692,531 $941,000
Q3 2019 Nov 14, 2019	SELL	$1.15 - $1.59 $38,980 - $53,894	-33,896 Reduced 4.6%	702,791 $934,000
Q2 2019 Aug 15, 2019	BUY	$1.37 - $2.02 $1.01 Million - $1.49 Million	736,687 New	736,687 $1.04 Million

Others Institutions Holding GERN

# of Institutions

258

Shares Held

448M

Call Options Held

1.91M

Put Options Held

897K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.73B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Geron Corp Transaction History